154 related articles for article (PubMed ID: 25637634)
41. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.
Potter BM; Xie LH; Vuong C; Zhang J; Zhang P; Duan D; Luong TL; Bandara Herath HM; Dhammika Nanayakkara NP; Tekwani BL; Walker LA; Nolan CK; Sciotti RJ; Zottig VE; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Marcsisin SR
Antimicrob Agents Chemother; 2015 Apr; 59(4):2380-7. PubMed ID: 25645856
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous determination of a new antimalarial agent, CDRI compound 80/53, and its metabolite primaquine in serum by high-performance liquid chromatography.
Paliwal JK; Gupta RC; Grover PK
J Chromatogr; 1993 Jun; 616(1):155-60. PubMed ID: 8376487
[TBL] [Abstract][Full Text] [Related]
43. Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach.
Sridharan K; Sannala CKR; Mallayasamy S; Chaturvedula A; Kadam P; Hase N; Shukla A; Gogtay N; Thatte U
Indian J Pharmacol; 2019; 51(1):17-24. PubMed ID: 31031463
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC-MS assay.
Page-Sharp M; Ilett KF; Betuela I; Davis TM; Batty KT
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():142-6. PubMed ID: 22771236
[TBL] [Abstract][Full Text] [Related]
45. [Study of pharmacokinetics of liver targeting antimalarial agent neoglycoalbumin-primaquine conjugate (NGA-PQ) and primaquine phosphate in mouse].
Li TL; Pang QJ; He YL; Wang P
Yao Xue Xue Bao; 1995; 30(10):721-5. PubMed ID: 8701725
[TBL] [Abstract][Full Text] [Related]
46. Measurements of 5,6-Orthoquinone, a Surrogate for the Presumed Active Primaquine Metabolite 5-Hydroxyprimaquine, in the Urine of Cambodian Adults.
Vanachayangkul P; Sea D; Wojnarski M; Sok S; Kodchakorn C; Ta-Aksorn W; Hom S; Ittiverakul M; Kuntawunginn W; Arsanok M; Buathong N; Heng TK; Nareth K; Nou S; Chandara S; Ly S; Oung P; Vesely B; Bennett J; Reichard G; Pybus B; Lanteri C; Saunders D; Fukuda M; Smith P; Dysoley L; Rekol H; Waters NC; Spring M
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0182121. PubMed ID: 34978892
[TBL] [Abstract][Full Text] [Related]
47. PHARMACOKINETICS OF PRIMAQUINE PHOSPHATE AFTER A SINGLE ORAL ADMINISTRATION TO AFRICAN PENGUINS (
Carag JH; Sander SJ; Kottyan J; Phillips J; Brubaker J; Cruz-Espindola C; Boothe D; Bronson E
J Zoo Wildl Med; 2021 Apr; 52(1):75-80. PubMed ID: 33827163
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
Mihaly GW; Ward SA; Edwards G; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1984 Apr; 17(4):441-6. PubMed ID: 6721990
[TBL] [Abstract][Full Text] [Related]
49. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
[TBL] [Abstract][Full Text] [Related]
50. Simultaneous determination of primaquine and carboxyprimaquine in plasma using high-performance liquid chromatography with electrochemical detection.
Dean RA; Ochieng W; Black J; Queener SF; Bartlett MS; Dumaual NG
J Chromatogr B Biomed Appl; 1994 Apr; 655(1):89-96. PubMed ID: 8061837
[TBL] [Abstract][Full Text] [Related]
51. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
[TBL] [Abstract][Full Text] [Related]
52. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine.
Singh KK; Vingkar SK
Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216
[TBL] [Abstract][Full Text] [Related]
53. Enantioselective analysis of primaquine and its impurity quinocide by capillary electrophoresis.
Elbashir AA; Saad B; Ali AS; Saleh MI; Aboul-Enein HY
Biomed Chromatogr; 2009 Mar; 23(3):295-301. PubMed ID: 18816453
[TBL] [Abstract][Full Text] [Related]
54. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
[TBL] [Abstract][Full Text] [Related]
55. Development and validation of a sensitive and selective UHPLC-MS/MS method for quantitation of an investigational anti-malarial compound, 2-tert-butylprimaquine (NP-96) in rat plasma, and its application in a preclinical pharmacokinetic study.
Mayatra SJ; Prasad B; Jain M; Jain R; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):410-5. PubMed ID: 19574014
[TBL] [Abstract][Full Text] [Related]
56. Biotransformation of primaquine in vitro with human K562 and bone marrow cells.
Frischer H; Ahmad T; Nora MV; Carson PE; Sivarajan M; Mellovitz R; Ptak L; Parkhurst GW; Chow HS; Kaizer H
J Lab Clin Med; 1987 Apr; 109(4):414-21. PubMed ID: 3819579
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, Biological Activity and In Silico Pharmacokinetic Prediction of a New 2-Thioxo-Imidazoldidin-4-One of Primaquine.
Pereira M; Caljon G; Gouveia MJ; Maes L; Vale N
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33673562
[TBL] [Abstract][Full Text] [Related]
58. Enantioselective HPLC-DAD method for the determination of etodolac enantiomers in tablets, human plasma and application to comparative pharmacokinetic study of both enantiomers after a single oral dose to twelve healthy volunteers.
Hewala II; Moneeb MS; Elmongy HA; Wahbi AA
Talanta; 2014 Dec; 130():506-17. PubMed ID: 25159440
[TBL] [Abstract][Full Text] [Related]
59. Interaction with Modified Cyclodextrin as a Way to Increase the Antimalarial Activity of Primaquine.
Torres LH; de Carvalho LB; de Fátima Abreu Venceslau A; Jaime C; de Matos Alves Pinto L
Curr Drug Discov Technol; 2020; 17(5):670-681. PubMed ID: 31438828
[TBL] [Abstract][Full Text] [Related]
60. Photoreactivity of biologically active compounds, XIV: influence of oxygen on light induced reactions of primaquine.
Kristensen S; Nord K; Orsteen AL; Tønnesen HH
Pharmazie; 1998 Feb; 53(2):98-103. PubMed ID: 9540107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
